Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Coagulation01:09

Coagulation

8.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.5K
Coagulation01:06

Coagulation

1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

11.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.1K
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

57
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
57

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular Vesicles in the Biology and Liquid Biopsy Diagnostics of Pediatric High-Grade Glioma - Emerging Findings and Opportunities.

Journal of extracellular biology·2026
Same author

An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastoma.

Signal transduction and targeted therapy·2026
Same author

Photoswitchable Silver(I) Complex with Anticancer and Antimicrobial Potential.

ACS omega·2026
Same author

Glioblastoma Cells Expressing Oncogenic EGFR Release Multiple Extracellular Vesicle Subpopulations Positive or Negative for EGFR.

Journal of extracellular biology·2026
Same author

Synthesis and characterization of Au@SiO<sub>2</sub>core-shell nanostructures for improved antibiotic delivery systems.

Nanomedicine : nanotechnology, biology, and medicine·2026
Same author

Synthesis and Biological Evaluation of 3,5-Diaryl-Substituted 1,2,4-Oxadiazole Sulfamates as Potent Steroid Sulfatase Inhibitors.

ACS medicinal chemistry letters·2026

Related Experiment Video

Updated: May 7, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.3K

Brain neoplasms and coagulation.

Nathalie Magnus1, Esterina D'Asti, Delphine Garnier

  • 1McGill University, The Research Institute of the McGill University Health Centre, Montreal Children's Hospital, Montreal, Quebec, Canada.

Seminars in Thrombosis and Hemostasis
|October 11, 2013
PubMed
Summary

Brain tumors hijack blood vessels, causing clotting and bleeding. Tissue factor (TF) and TF-containing microparticles (TF-MPs) play key roles in brain tumor progression and associated thromboembolic disease.

More Related Videos

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

147
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

16.5K

Related Experiment Videos

Last Updated: May 7, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.3K
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

147
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

16.5K

Area of Science:

  • Neuro-oncology
  • Vascular Biology
  • Hemostasis and Thrombosis

Background:

  • Brain vasculature is critical for CNS tissue protection and metabolic support.
  • Tumor development disrupts normal vasculature, leading to thrombosis and hemorrhage.
  • Glioblastoma multiforme (GBM) exhibits chronic coagulation activation, contributing to hypoxia and angiogenesis.

Purpose of the Study:

  • To investigate the role of the coagulation system, particularly tissue factor (TF), in brain tumor pathogenesis.
  • To explore the contribution of TF and TF-containing microparticles (TF-MPs) to thrombosis and thromboembolic disease in brain tumors.
  • To examine subtype-specific mechanisms of coagulation within different brain tumor molecular subtypes.

Main Methods:

  • Analysis of TF expression and TF-MP production in various brain tumors.
  • Investigation of regulatory mechanisms of TF expression by tumor microenvironment and oncogenic pathways.
  • Molecular stratification of brain tumors based on distinct oncogenic networks and coagulome composition.

Main Results:

  • Elevated TF expression and TF-MP production are observed in GBM and other brain tumors.
  • TF expression and MP release are modulated by hypoxia, oncogenic pathways (RAS, EGFR, MET), and tumor suppressor loss (PTEN).
  • Brain tumor subtypes (e.g., GBM, medulloblastoma) show distinct coagulome compositions.

Conclusions:

  • The TF pathway is a significant contributor to brain tumor pathogenesis, dormancy, inflammation, angiogenesis, and dissemination.
  • Understanding molecular linkages between TF, TF-MPs, and coagulation is crucial for targeted therapies.
  • Molecular stratification of patients may enable more effective therapies, prophylaxis, and anticoagulation strategies for brain tumors.